Stay ahead of the competition at every stage

Pharmaceutical drug discovery and development is a tremendously competitive field. In an increasing number of countries, a company must be first or best in class to gain market access.

Generating “me too” compounds is no longer a strategic option for companies.

Continuous analysis and monitoring of competitive intelligence across the entire drug development spectrum is essential as your asset progresses through the pipeline - from target identification to life cycle management and generic competition.

We can help you closely monitor your competitors, understand target landscape, stay informed on the latest news in your industry, and bring intelligence from numerous sources together into customized dashboards.

Understand pharma R&D productivity metrics to stay ahead of the game

R&D productivity across the global biopharmaceutical industry is a frequently discussed topic. When planning your long term R&D strategy, you want to know: How much will you have to spend on R&D over the coming years? Which therapeutic areas have seen positive growth in pipeline volume and are absorbing the majority of investment? How do the cycle times and attrition rates vary among therapeutic areas?

Our experts at the Centre for Medicines Research International have gathered authoritative, robust industry metrics for every stage of pharmaceutical development and can provide a detailed analysis for your space to inform and steer your R&D strategy.

Find the right partners, do the right deals

Few companies these days can manage their product portfolios without relying on either in-licensing or out-licensing.

Effective monitoring and assessment of drug development and deal making activity is essential to focus on the best opportunities.

Our solutions can help you track your closest competitors at every stage of the drug development process, identify and assess desirable assets and partners and gain insights into critical deal making trends.